Barbara L. Weber
Affiliations: | University of Pennsylvania, Philadelphia, PA, United States |
Area:
Genetics, Cell Biology, Molecular BiologyGoogle:
"Barbara Weber"Children
Sign in to add trainee| Meredith A. Unger | grad student | 2002 | Penn |
| Dimitra Tsavachidou | grad student | 2005 | Penn |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Huang A, Garraway LA, Ashworth A, et al. (2019) Synthetic lethality as an engine for cancer drug target discovery. Nature Reviews. Drug Discovery |
| Pitt JJ, Riester M, Zheng Y, et al. (2018) Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features. Nature Communications. 9: 4181 |
| Hu Z, Mao JH, Curtis C, et al. (2017) Erratum to: Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer. Breast Cancer Research : Bcr. 19: 17 |
| Hu Z, Mao JH, Curtis C, et al. (2016) Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer. Breast Cancer Research : Bcr. 18: 70 |
| Li N, Kaur S, Greshock J, et al. (2012) A combined array-based comparative genomic hybridization and functional library screening approach identifies mir-30d as an oncomir in cancer. Cancer Research. 72: 154-64 |
| Maxwell CA, Benítez J, Gómez-Baldó L, et al. (2011) Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. Plos Biology. 9: e1001199 |
| Huang J, Zhang L, Greshock J, et al. (2011) Frequent genetic abnormalities of the PI3K/AKT pathway in primary ovarian cancer predict patient outcome. Genes, Chromosomes & Cancer. 50: 606-18 |
| Degenhardt Y, Greshock J, Laquerre S, et al. (2010) Sensitivity of cancer cells to Plk1 inhibitor GSK461364A is associated with loss of p53 function and chromosome instability. Molecular Cancer Therapeutics. 9: 2079-89 |
| Gilbert PM, Mouw JK, Unger MA, et al. (2010) HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype. The Journal of Clinical Investigation. 120: 1535-50 |
| Balamuth NJ, Wood A, Wang Q, et al. (2010) Serial transcriptome analysis and cross-species integration identifies centromere-associated protein E as a novel neuroblastoma target. Cancer Research. 70: 2749-58 |